On October 15, 2026, Profusa issued a Senior Secured Convertible Promissory Note with a principal amount of $769,230.77 for a purchase price of $700,000 to Ascent Partners Fund LLC under an existing Securities Purchase Agreement. The note bears interest at 7% per annum and matures on October 15, 2027 or upon the closing of a previously announced option exercise. It is convertible into common stock at $4.28 per share, subject to a floor price of $1.07. Monthly amortization payments begin January 1, 2027, and the note is secured by intellectual property assets. Profusa develops photobiomodulation technologies for medical devices.
